Reimbursement Status of Newer Drugs for the Treatment of Type 2 Diabetes


Project Status:
Project Line:
Health Technology Review
Project Sub Line:
Environmental Scan
Project Number:

This project aims to retrieve and summarize the formulary status of drugs pertaining to three classes used for the treatment of type 2 diabetes; i.e., dipeptidyl-peptidase 4 (DPP-4) inhibitors, sodium-glucose cotransporter-2 (SGLT-2) inhibitors, and glucagon-like peptide 1 (GLP-1) agonists. Information will be retrieved from the website of all publicly funded provincial, territorial, and federal drug plans in Canada.


Reimbursement of Newer Drugs for Type 2 Diabetes in Canada: An Environmental Scan

Environmental Scans
PUBLISHED: February 2019